Resilience and Lilly invest $750M to boost Cincinnati drug production
The expansion will create 400 jobs dedicated to making GLP-1 injectables across Resilience’s contract manufacturing facilities.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.